NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-195649 |   Pharmaceuticals And Medical

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Nucleic Acid Isolation and Purification (NAIP) Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET

7.1 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION (NAIP) MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Qiagen NV

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Thermo Fisher Scientific

16.3 F Hoffman-La Roche AG

16.4 Promega Corporation

16.5 Agilent Technologies

16.6 Bio-Rad Laboratories

16.7 Danaher Corporation

16.8 GE Healthcare

16.9 Illumina

16.10 Merck Kgaa

16.11 Takara Bio Inc

16.12 New England Biolabs

16.13 Zymo Research

16.14 Norgen Biotek

16.15 Omega Bio-Tek Inc

16.16 Other Companies

16.17 Genaxxon Bioscience GmbH

16.18 3B Blackbio Biotech India Ltd

16.19 Invitek Molecular GmbH

16.20 Biovision

16.21 Analytik Jena AG

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Kits
Reagents
Instruments

By Application
Diagnostics
Research
Industry, Environmental, Food Quality Control
Drug Discovery & Development
Personalized Medicine
Agriculture & Animal Research
Other

Companies

Qiagen NV
Thermo Fisher Scientific
F Hoffman-La Roche AG
Promega Corporation
Agilent Technologies
Bio-Rad Laboratories
Danaher Corporation
GE Healthcare
Illumina
Merck Kgaa
Takara Bio Inc
New England Biolabs
Zymo Research
Norgen Biotek
Omega Bio-Tek Inc
Other Companies
Genaxxon Bioscience GmbH
3B Blackbio Biotech India Ltd
Invitek Molecular GmbH
Biovision
Analytik Jena AG

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.